Making Strategic Acquisitions

A team of GE Healthcare employees coordinated our acquisition of an important new partner—Clarient, a California-based, 400-person leading player in the fast-growing molecular diagnostics sector. Combining the skills of the two companies will allow us to help pathologists and oncologists make more confident clinical decisions, bringing improvements in the quality of patient care and lowering costs. The partnership will bring GE into the next realm of diagnostic technology, accelerating our presence in cancer diagnostics, where demand is expected to grow from $15 billion today to $47 billion by 2015.